BRCA1-dependent ubiquitination of γ-tubulin regulates centrosome number

Molecular and Cellular Biology

Volumn 24, Issue 19, 2004, Pages 8457-8466

  Starita, Lea M ^a   Machida, Yuka ^a   Sankaran, Satish ^a   Elias, Joshua E ^b   Griffin, Karen ^a   Schlegel, Brian P ^a,c   Gygi, Steven P ^b   Parvin, Jeffrey D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; GAMMA TUBULIN; PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BREAST; CARBOXY TERMINAL SEQUENCE; CELL LINE; CENTROSOME; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; SEQUENCE ANALYSIS; UBIQUITINATION;

BRCA1 PROTEIN; CENTROSOME; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LYSINE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TUBULIN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 4544240599     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.19.8457-8466.2004     Document Type: Article

References (47)

1. Anderson, S. F., B. P. Schlegel, T. Nakajima, E. S. Wolpin, and J. D. Parvin. 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19:254-256.
2. Arita, D., M. Kambe, C. Ishioka, and R. Kanamaru. 1997. Induction of p53-independent apoptosis associated with G2M arrest following DNA damage in human colon cancer cell lines. Jpn. J. Cancer Res. 88:39-43.
3. Bartek, J., J. Bartkova, N. Kyprianou, E. N. Lalani, Z. Staskova, M. Shearer, S. Chang, and J. Taylor-Papadimitriou. 1991. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Acad. Sci. USA 88:3520-3524.
4. Berdichevsky, F., and J. Taylor-Papadimitriou. 1991. Morphological differentiation of hybrids of human mammary epithelial cell lines is dominant and correlates with the pattern of expression of intermediate filaments. Exp. Cell Res. 194:267-274.
5. Bornens, M., M. Paintrand, J. Berges, M. C. Marty, and E. Karsenti. 1987. Structural and chemical characterization of isolated centrosomes. Cell. Motil. Cytoskeleton 8:238-249.
6. Brzovic, P. S., P. Rajagopal, D. W. Hoyt, M. C. King, and R. E. Klevit. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8:833-837.
7. Carroll, A. G., H. J. Voeller, L. Sugars, and E. P. Gelmann. 1993. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23:123-134.
8. Chen, A., F. E. Kleiman, J. L. Manley, T. Ouchi, and Z. Q. Pan. 2002. Autoubiquitination of the BRCAI*BARD1 RING ubiquitin ligase. J. Biol. Chem. 277:22085-22092.
9. Deng, C. X. 2002. Roles of BRCA1 in centrosome duplication. Oncogene 21:6222-6227.
10. Dong, Y., M. A. Hakimi, X. Chen, E. Kumaraswamy, N. S. Cooch, A. K. Godwin, and R. Shiekhattar. 2003. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol. Cell 12:1087-1099.
11. Ducret, A., I. Van Oostveen, J. K. Eng, J. R. Yates III, and R. Aebersold. 1998. High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry. Protein Sci. 7:706-719.
12. Freed, E., K. R. Lacey, P. Huie, S. A. Lyapina, R. J. Deshaies, T. Stearns, and P. K. Jackson. 1999. Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle. Genes Dev. 13:2242-2257.
13. Fukasawa, K., T. Choi, R. Kuriyama, S. Rulong, and G. F. Vande Woude. 1996. Abnormal centrosome amplification in the absence of p53. Science 271:1744-1747.
14. Ganesan, S., D. P. Silver, R. A. Greenberg, D. Avni, R. Drapkin, A. Miron, S. C. Mok, V. Randrianarison, S. Brodie, J. Salstrom, T. P. Rasmussen, A. Klimke, C. Marrese, Y. Marahrens, C. X. Deng, J. Feunteun, and D. M. Livingston. 2002. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 111:393-405.
15. Hashizume, R., M. Fukuda, I. Maeda, H. Nishikawa, D. Oyake, Y. Yabuki, H. Ogata, and T. Ohta. 2001. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276:14537-14540.
16. Hsu, L. C., T. P. Doan, and R. L. White. 2001. Identification of a gamma-tubulin-binding domain in BRCA1. Cancer Res. 61:7713-7718.
17. Hsu, L. C., and R. L. White. 1998. BRCA1 is associated with the centrosome during mitosis. Proc. Natl. Acad. Sci. USA 95:12983-12988.
18. Ito, T., M. E. Levenstein, D. V. Fyodorov, A. K. Kutach, R. Kobayashi, and J. T. Kadonaga. 1999. ACF consists of two subunits, Acfl and ISWI, that function cooperatively in the ATP-dependent catalysis of chromatin assembly. Genes Dev. 13:1529-1539.
19. Jeffy, B. D., R. B. Chirnomas, E. J. Chen, J. M. Gudas, and D. F. Romagnolo. 2002. Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t, 10-epoxy-7,8,9,10-tetrahydro-benzo[a] pyrene. Cancer Res. 62:113-121.
20. Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
21. Lingle, W. L., S. L. Barrett, V. C. Negron, A. B. D'Assoro, K. Boeneman, W. Liu, C. M. Whitehead, C. Reynolds, and J. L. Salisbury. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. USA 99:1978-1983.
22. Lingle, W. L., and J. L. Salisbury. 2001. Methods for the analysis of centrosome reproduction in cancer cells. Methods Cell Biol. 67:325-336.
23. Lotti, L. V., L. Ottini, C. D'Amico, R. Gradini, A. Cama, F. Belleudi, L. Frati, M. R. Torrisi, and R. Mariani-Costantini. 2002. Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer 35:193-203.
24. Lyakhovich, A., and M. P. Shekhar. 2003. Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response. Mol. Cell. Biol. 23:2463-2475.
25. Mallery, D. L., C. J. Vandenberg, and K. Hiom. 2002. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 21:6755-6762.
26. Matlashewski, G., L. Banks, D. Pim, and L. Crawford. 1986. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur. J. Biochem. 154:665-672.
27. Meraldi, P., J. Lukas, A. M. Fry, J. Bartek, and E. A. Nigg. 1999. Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat. Cell Biol. 1:88-93.
28. Mitsui, A., and P. A. Sharp. 1999. Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain. Proc. Natl. Acad. Sci. USA 96:6054-6059.
29. Nakatani, Y., and V. Ogryzko. 2003. Immunoaffinity purification of mammalian protein complexes. Methods Enzymol. 370:430-444.
30. Nieves-Neira, W., and Y. Pommier. 1999. Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI Anticancer Drug Screen: multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways. Int. J. Cancer 82:396-404.
31. Peng, J., and S. P. Gygi. 2001. Proteomics: the move to mixtures. J. Mass Spectrom. 36:1083-1091.
32. Piel, M., J. Nordberg, U. Euteneuer, and M. Bornens. 2001. Centrosome-dependent exit of cytokinesis in animal cells. Science 291:1550-1553.
33. Pihan, G. A., J. Wallace, Y. Zhou, and S. J. Doxsey. 2003. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 63:1398-1404.
34. Rothmann, T., A. Hengstermann, N. J. Whitaker, M. Scheffner, and H. zur Hausen. 1998. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72:9470-9478.
35. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
36. Schlegel, B. P., L. M. Starita, and J. D. Parvin. 2003. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells. Oncogene 22:983-991.
37. Starita, L. M., and J. D. Parvin. 2003. The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair. Curr. Opin. Cell Biol. 15:345-350.
38. Szabo, C. I., and M. C. King. 1995. Inherited breast and ovarian cancer. Hum. Mol. Genet. 4:1811-1817.
39. Takada, S., A. Kelkar, and W. E. Theurkauf. 2003. Drosophila checkpoint kinase 2 couples centrosome function and spindle assembly to genomic integrity. Cell 113:87-99.
40. Treier, M., L. M. Staszewski, and D. Bohmann. 1994. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78:787-798.
41. Venkitaraman, A. R. 2002. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 108:171-182.
42. Wojcik, E. J., D. M. Glover, and T. S. Hays. 2000. The SCF ubiquitin ligase protein Slimb regulates centrosome duplication in Drosophila. Curr. Biol. 10:1131-1134.
43. Wu, L. C., Z. W. Wang, J. T. Tsan, M. A. Spillman, A. Phung, X. L. Xu, M. C. Yang, L. Y. Hwang, A. M. Bowcock, and R. Baer. 1996. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14:430-440.
44. Wu-Baer, F., K. Lagrazon, W. Yuan, and R. Baer. 2003. The BRCA1/BARDI heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J. Biol. Chem. 278:34743-34746.
45. Xia, Y., G. M. Pao, H. W. Chen, I. M. Verma, and T. Hunter. 2003. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 278:5255-5263.
46. 2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3:389-395.
47. Zhang, H., K. Somasundaram, Y. Peng, H. Tian, D. Bi, B. L. Weber, and W. S. El-Deiry. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16:1713-1721.